The Global Benign Prostatic Hypertrophy Implant Devices Market is expected to register a CAGR of over 14% during the forecast period 2022 to 2028. Benign prostatic hyperplasia (BPH) is an enlarged prostate, not cancer. Benign prostatic hyperplasia and benign prostatic obstruction are terms used to describe this condition. Men over the age of 50 are most […]